Form 4: Agilent CEO Exercises Options, Sells Shares

Agilent Technologies' President and CEO, Padraig McDonnell, executed a pre-arranged plan to exercise stock options and sell common stock.

Summary

• Padraig McDonnell, President and CEO of Agilent Technologies, Inc., engaged in transactions involving the company's common stock.
• On November 12, 2025, Mr. McDonnell exercised employee stock options to acquire 12,490 shares of common stock at an exercise price of $109.86 per share.
• Concurrently, he sold 12,490 shares of common stock at a price of $150 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 Plan adopted by Mr. McDonnell on March 28, 2025.
• Following these transactions, Mr. McDonnell directly beneficially owns 33,448 shares of Agilent Technologies common stock.
• The options were originally granted on November 17, 2020, and became exercisable in four equal annual installments starting November 17, 2021, with an expiration date of November 17, 2030.

Sentiment

Score: 6

Explanation: The transaction is a routine insider sale under a 10b5-1 plan, indicating a planned liquidity event rather than a reaction to new information. The insider realized a profit, which is a positive for the individual, but the sale itself is neutral to slightly negative from a market sentiment perspective, as it's a reduction in insider holdings.

Positives

• The exercise of options and subsequent sale resulted in a profit for the insider, as shares were acquired at $109.86 and sold at $150.
• The transactions were executed under a pre-arranged Rule 10b5-1 Plan, indicating a planned liquidity event rather than a reaction to new, undisclosed information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, although it is often for personal financial planning or diversification.

Future Outlook

This Form 4 filing is purely transactional and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction filing does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale of shares by a high-ranking executive could be interpreted by some shareholders as a signal, though the 10b5-1 plan mitigates concerns about opportunistic selling. The overall impact is likely minimal given the routine nature of such transactions.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction (option exercise and sale) executed under a pre-arranged 10b5-1 plan. While the insider realized a profit, the transaction itself does not provide new fundamental information about Agilent Technologies' operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. It's a common personal financial management activity for executives, and therefore, a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Agilent Technologies, A, Form 4, insider transaction, stock options, CEO, Padraig McDonnell, 10b5-1 plan, equity sale